Annual Meeting 2027 of the Japanese Society for Patient-Derived Cancer Models 【Tokyo】

科学・医療分野の学会で、研究者がスクリーンを使って研究成果を発表し、参加者が聴講する様子
             

Event Details

  • Date: –

Patient-Derived Cancer Models / PDX / Organoids / Drug Discovery / Japan

Annual Meeting 2027 of the Japanese Society for Patient-Derived Cancer Models 【Tokyo】

The Annual Meeting 2027 of the Japanese Society for Patient-Derived Cancer Models will take place on December 8–10, 2027, at the National Cancer Center Research Institute in Tsukiji, Chuo-ku, Tokyo, Japan. The meeting provides a forum for researchers involved in the establishment, analysis and application of cancer models using clinical specimens, including patient-derived cancer cell lines, patient-derived xenografts (PDX) and patient-derived organoids (PDO). It is relevant to research connecting fundamental cancer biology with pharmaceutical development, including studies of cancer mechanisms, evaluation of anticancer drug efficacy and translational research.

Date
December 8–10, 2027
Venue
National Cancer Center Research Institute
Organizer
Japanese Society for Patient-Derived Cancer Models
Field
Patient-Derived Cancer Models and Drug Discovery

Meeting Overview and Objectives

The Japanese Society for Patient-Derived Cancer Models (JSPCM) is a scientific society that promotes interaction among researchers involved in developing and applying patient-derived cancer models. Established in 2022, the society builds on scientific meetings that began in 2017 and supports their continued development.

Patient-derived cancer models are research tools that use tumor tissues or cells obtained from patients to investigate the biological characteristics of cancer. They are used to understand disease mechanisms and gene and protein functions, evaluate the efficacy of new anticancer agents and investigate treatment responses.

The Annual Meeting 2027 is a three-day scientific meeting relevant to researchers involved in fundamental cancer model research, clinical applications and drug discovery. Following the conclusion of the 2026 meeting, the official event website announced that the next meeting would be held on December 8–10, 2027.

Official information: Japanese Society for Patient-Derived Cancer Models (Japanese)

JSPCM Annual Meeting 2027: Event Information

  • Official Japanese name: 日本患者由来がんモデル学会 学術集会2027
  • English name: Annual Meeting 2027 of the Japanese Society for Patient-Derived Cancer Models (English rendering)
  • Dates: December 8 (Wed)–December 10 (Fri), 2027
  • Meeting hours: Under preparation
  • Venue: National Cancer Center Research Institute
  • Address: 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
  • Organizer: Japanese Society for Patient-Derived Cancer Models (JSPCM)
  • Meeting Chair: Under preparation
  • Meeting theme: Under preparation
  • Format: The venue has been announced. Streaming arrangements and other details are under preparation.

The specific building, lecture rooms and registration desk for the 2027 meeting are under preparation. While the 2026 meeting took place on August 19–21, the 2027 meeting will be held in December.

Official information: Official Meeting Website and Next Meeting Announcement

Organizer, Society and Administration

  • Organizer: Japanese Society for Patient-Derived Cancer Models
  • Society Representative: Dr. Tadashi Kondo (National Cancer Center Research Institute)
  • Society established: 2022
  • Society Secretariat: Division of Rare Cancer Research, National Cancer Center
  • Society Secretariat Address: 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
  • 2027 Meeting Chair: Under preparation
  • 2027 meeting administration: Listed in the 2027 convention schedule of A&E Planning Co., Ltd. Dedicated meeting contact details are under preparation.

The society representative and the Chair of the 2027 Annual Meeting are separate roles. Please refer to forthcoming official announcements for the 2027 Meeting Chair, organizing committee and meeting secretariat.

Official information: Japanese Society for Patient-Derived Cancer Models / A&E Planning: 2027 Convention Schedule (Japanese)

Related Research Fields and Key Technologies

Patient-derived cancer models are used to study cancer heterogeneity and treatment responses. Understanding the characteristics and limitations of each model and selecting appropriate models for specific research objectives are important considerations.

  • Patient-derived xenografts (PDX): Models generated by transplanting patient tumor tissue into immunodeficient mice or other suitable hosts to investigate tumor characteristics and drug responses.
  • Patient-derived organoids (PDO): Three-dimensional culture models derived from patient tumor cells for investigating cancer biology and drug responses.
  • Patient-derived cancer cell lines: Cells established from clinical specimens for studies of molecular mechanisms, gene functions and drug evaluation.
  • Tumor microenvironment (TME): Research on interactions among cancer cells, immune cells and stromal cells, including the spatial characteristics of tumors.
  • Drug discovery and efficacy assessment: Evaluation of candidate anticancer agents, drug sensitivity, resistance mechanisms and therapeutic target identification.
  • Molecular analysis and data science: Cancer research using genomics, proteomics, single-cell analysis, spatial omics and artificial intelligence.
  • Rare cancers and biological resources: Establishment, quality assessment, preservation and use of patient-derived cancer models as research resources, including models of rare cancers.

These are examples of research areas associated with patient-derived cancer models. They are not confirmed lecture topics or official abstract categories for the Annual Meeting 2027.

Program and Call for Abstracts

The dates and venue of the Annual Meeting 2027 have been announced. The detailed scientific program and abstract submission requirements are under preparation.

  • Meeting theme: Under preparation
  • Detailed program and schedule: Under preparation
  • Special lectures and symposia: Under preparation
  • Abstract submission period: Under preparation
  • Submission procedure and eligibility: Under preparation
  • Poster and oral presentation guidelines: Under preparation

Researchers planning to submit abstracts should consult the official submission guidelines for the 2027 meeting. The program and presentation requirements of the 2026 meeting may not apply to the upcoming event.

Official information: Official Meeting Website

Registration, Fees and Potential Attendees

  • Advance registration period: Under preparation
  • Registration procedure: Under preparation
  • Registration fees: Under preparation
  • Participation eligibility and membership categories: Under preparation
  • On-site registration and networking event: Under preparation

The meeting is relevant to cancer researchers, clinicians, researchers in pathology and molecular diagnostics, drug discovery and nonclinical research professionals in pharmaceutical and biotechnology companies, and graduate students.

Registration fees and participation requirements for the 2027 meeting have not been confirmed. Please consult forthcoming official registration information rather than relying on fees from the previous meeting.

Corporate Exhibitions, Sponsorship and Drug Discovery Technologies

Exhibitions and advertising: Listed in the convention schedule

The 2027 convention schedule published by A&E Planning Co., Ltd. indicates exhibitions and advertising for this meeting. Specific application guidelines and application availability are under preparation.

Patient-derived cancer model research is associated with technologies such as three-dimensional cell culture, cell culture substrates, organoid culture reagents, cellular analysis instruments, imaging, multiplex immunofluorescence, spatial omics, drug efficacy assessment, high-throughput screening and laboratory automation. These research fields are also relevant to pharmaceutical companies, research instrument and reagent manufacturers, drug discovery service providers and contract research organizations (CROs).

  • Corporate exhibitions: Listed in the convention schedule. Application details are under preparation.
  • Advertising: Listed in the convention schedule. Application details are under preparation.
  • Sponsorship packages and exhibition fees: Under preparation
  • Application opening dates and deadlines: Under preparation
  • Corporate presentations and co-sponsored seminars: Under preparation

Companies considering exhibitions or advertising should consult the latest official information for application requirements.

Official information: A&E Planning: 2027 Convention Schedule (Japanese)

Venue and Access

National Cancer Center Research Institute (Tsukiji Campus)
5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan

The National Cancer Center Research Institute conducts research on the molecular mechanisms of cancer development and progression, cancer genomics, drug discovery and translational research. Its Tsukiji Campus is located in Chuo-ku, Tokyo, and is accessible via several subway lines.

  • Approximately 3 minutes on foot from Exit A1 of Tsukijishijo Station on the Toei Oedo Line.
  • Approximately 5 minutes on foot from Exit 2 of Tsukiji Station on the Tokyo Metro Hibiya Line.
  • Approximately 6 minutes on foot from Exit 6 of Higashi-ginza Station on the Tokyo Metro Hibiya Line or Toei Asakusa Line.
  • Approximately 9 minutes on foot from Exit 4 of Shintomicho Station on the Tokyo Metro Yurakucho Line.

The specific building, lecture rooms and registration desk for the 2027 meeting are under preparation. They may differ from the first-floor venue in the New Research Center Building used for the 2026 meeting. Please check the latest meeting announcements before your visit.

Official information: National Cancer Center: Access Map (English) / Research Institute: Transportation Access (Japanese)

Official Websites

JSPCM Annual Meeting 2027: Next Meeting Announcement

Japanese Society for Patient-Derived Cancer Models

A&E Planning: 2027 Convention Schedule (Japanese)

National Cancer Center Research Institute (English)

Venue and Transportation Access (English)

Information checked November 16, 2026. Meeting dates and venue are based on the next meeting announcement on the official 2026 meeting website and the 2027 convention schedule of A&E Planning. Please refer to forthcoming official announcements for the 2027 meeting theme, program, abstract submission, registration, exhibitions and sponsorship information. Meeting details and dates are subject to change.